The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR of 8.2% over the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel therapies, increasing R&D activities, and the rising awareness for the diagnosis and treatment of growth hormone (GH) disorders are expected to drive the market over the forecast period.
Key players operating in the market are involved in extensive R&D activities for the development of novel GH therapies to strengthen their position in the market. For instance, in October 2019, VISEN Pharmaceuticals, a joint venture of Denmark-based Ascendis Pharma A/S, received approval from the China National Drug Administration (NMPA) for its new drug (IND) application to start Phase III clinical study of TransCon hGH. Furthermore, two South Korean companies, Genexine Inc. and Handok Inc. are conducting a Phase II clinical trial study on GX-H9, a recombinant human GH for the treatment of adult and pediatric GH deficiency.
Furthermore, an increase in the number of regulatory approvals and the launch of novel HGH therapies are expected to fuel the market over the forecast period. For instance, in January 2018, Ferring Pharmaceuticals Inc., a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for its new recombinant HGH, Zomacton (somatropin), indicated for the treatment of adult patients with GH deficiency.
Various government and private organizations have been undertaking initiatives and programs to spread awareness about GH deficiency and facilitate timely diagnosis and treatment. Nonprofit organizations such as the Human Growth Foundation are engaged in providing research support and spreading awareness about GH deficiency and its treatment. Such initiatives are expected to drive the demand for hGH treatment therapies.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/human-growth-hormone-drugs-market
Human Growth Hormone Market Report Highlights
• GH deficiency was the largest application segment in 2019 owing to an increase in regulatory approvals and the launch of novel therapies
• Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital pharmacy distribution channel segment
• North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
• Asia Pacific is projected to witness a lucrative CAGR over the forecast period owing to increasing penetration of key players with their new growth hormone therapies.
• The key players include Novo Nordisk A/S; Pfizer Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen.
For Requesting a Sample Copy Please Visit @ https://www.grandviewresearch.com/industry-analysis/human-growth-hormone-drugs-market/request/rs15
Human Growth Hormone Market Segmentation
Grand View Research has segmented the global human growth hormone market on the basis of application, distribution channel, and region:
Human Growth Hormone (HGH) Application Outlook (Revenue, USD Million, 2016 - 2027)
• Growth Hormone (GH) Deficiency
• Adult GH Deficiency
• Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small for Gestational Age
• Other
Human Growth Hormone (HGH) Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Specialty Pharmacy
Human Growth Hormone (HGH) Regional Outlook (Revenue, USD Million, 2016 - 2027)
• North America
• The U.S.
• Canada
• Europe
• Germany
• The U.K.
• Spain
• Italy
• France
• Russia
• Asia Pacific
• China
• India
• Japan
• Singapore
• South Korea
• Australia
• Central and South America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
List of Key Players of Human Growth Hormone Market
• Novo Nordisk A/S
• Pfizer Inc.
• Eli Lilly and Company
• Sandoz International GmbH (Novartis AG)
• Merck KGaA
Fill the Pre-Order Enquiry Form for the Report @ https://www.grandviewresearch.com/inquiry/773/ibb
Browse Related Reports:
Hormone Replacement Therapy MarketSize, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027.
About Grand View Research
Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/human-growth-hormone-drugs-market
